Drug Discovery Biology and Department of Pharmacology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, VIC, Australia.
The CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; Center for Cancer and Cell Biology, Innovation and Integration Program, Van Andel Research Institute, Grand Rapids, MI, USA.
Mol Cell. 2020 Feb 6;77(3):656-668.e5. doi: 10.1016/j.molcel.2020.01.012. Epub 2020 Jan 30.
Class B G protein-coupled receptors (GPCRs) are important therapeutic targets for major diseases. Here, we present structures of peptide and Gs-bound pituitary adenylate cyclase-activating peptide, PAC1 receptor, and corticotropin-releasing factor (CRF), (CRF1) receptor. Together with recently solved structures, these provide coverage of the major class B GPCR subfamilies. Diverse orientations of the extracellular domain to the receptor core in different receptors are at least partially dependent on evolutionary conservation in the structure and nature of peptide interactions. Differences in peptide interactions to the receptor core also influence the interlinked TM2-TM1-TM6/ECL3/TM7 domain, and this is likely important in their diverse signaling. However, common conformational reorganization of ECL2, linked to reorganization of ICL2, modulates G protein contacts. Comparison between receptors reveals ICL2 as a key domain forming dynamic G protein interactions in a receptor- and ligand-specific manner. This work advances our understanding of class B GPCR activation and Gs coupling.
B 类 G 蛋白偶联受体 (GPCR) 是治疗多种重大疾病的重要靶点。本文报告了肽和 Gs 偶联的垂体腺苷酸环化酶激活肽、PAC1 受体和促肾上腺皮质激素释放因子 (CRF) (CRF1) 受体的结构。与最近解决的结构一起,这些结构覆盖了主要的 B 类 GPCR 亚家族。不同受体中细胞外结构域与受体核心的不同取向至少部分取决于肽相互作用的结构和性质的进化保守性。与受体核心的肽相互作用的差异也会影响相互关联的 TM2-TM1-TM6/ECL3/TM7 结构域,这在它们的多样性信号传导中可能很重要。然而,ECL2 的共同构象重排与 ICL2 的重排相关,调节 G 蛋白的接触。受体间的比较表明,ICL2 是一种关键结构域,以受体和配体特异性的方式形成动态 G 蛋白相互作用。这项工作推进了我们对 B 类 GPCR 激活和 Gs 偶联的理解。